drugset / Trial / NCT00324389

Interferon-Induced Gene Expression in Liver Cells and Peripheral Blood Lymphocytes

NCT00324389

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This proposal seeks to use DNA analyses to understand how racial and genetic factors influence interferon (treatment) response in HCV infection in African Americans. A better understanding should allow rational design of new therapies or better use of existing therapies. Patients will provide medical history and undergo a physical exam, blood draws, electrocardiogram, possible chest x-ray, and abdominal ultrasound. Patients will be admitted to the hospital for 5 days and undergo 2 liver biopsies, sedation, and multiple blood draws. Twenty adult male volunteers (10 Caucasians,10 African Americans) ages 18 - 65 years will participate.

Timeline

Start
2006-05
Primary completion
Completion
2006-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Interferon Protein / enzyme biologic 1e+07 iu Subcutaneous